- TWD33.74bn
- TWD29.19bn
- TWD6.91bn
- 86
- 15
- 95
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,949 | 3,580 | 4,684 | 5,650 | 6,912 |
Cost of Revenue | |||||
Gross Profit | 1,384 | 1,456 | 1,707 | 2,090 | 2,206 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,562 | 3,141 | 4,103 | 4,933 | 6,115 |
Operating Profit | 388 | 439 | 581 | 717 | 797 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 403 | 389 | 524 | 736 | 860 |
Provision for Income Taxes | |||||
Net Income After Taxes | 323 | 305 | 420 | 569 | 650 |
Net Income Before Extraordinary Items | |||||
Net Income | 323 | 305 | 420 | 569 | 650 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 323 | 305 | 420 | 569 | 650 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.93 | 4.01 | 4.94 | 6.94 | 7.3 |
Dividends per Share |